Cargando…
Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy–Induced Diabetes Mellitus
Cancer immunotherapies are changing the landscape of cancer care. Intratumoral talimogene iaherparepvec (T-VEC), an oncolytic viral vaccine, has been approved for treatment of unresectable melanoma with minimal toxicity. We describe the first case of a centenarian who developed autoimmune diabetes w...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491923/ https://www.ncbi.nlm.nih.gov/pubmed/32964173 http://dx.doi.org/10.1210/jendso/bvaa114 |